Abstract
Acute kidney injury (AKI), once viewed predominantly as a self-limited and reversible condition, is now recognized as a growing problem associated with significant risks of adverse long-term health outcomes. Many cohort studies have established important relationships between AKI and subsequent risks of recurrent AKI, hospital re-admission, morbidity and mortality from cardiovascular disease and cancer, as well as the development of chronic kidney disease and end-stage kidney disease. In both high-income countries (HICs) and low-income or middle-income countries (LMICs), several challenges exist in providing high-quality, patient-centered care following AKI. Despite advances in our understanding about the long-term risks following AKI, large gaps in knowledge remain about effective interventions that can improve the outcomes of patients. Therapies for high blood pressure, glycaemic control (for patients with diabetes), renin–angiotensin inhibition and statins might be important in improving long-term cardiovascular and kidney outcomes after AKI. Novel strategies that incorporate risk stratification approaches, educational interventions and new models of ambulatory care following AKI have been described, and some of these are now being implemented and evaluated in clinical studies in HICs. Care for AKI in LMICs must overcome additional barriers due to limited resources for diagnosis and management.
Key points
-
Acute kidney injury (AKI) is a common and costly clinical syndrome that affects nearly one-quarter of all hospitalized patients worldwide.
-
Although AKI was previously often perceived as a self-limited condition, it is now clear that acute changes in kidney function are associated with long-term consequences, including progression to chronic kidney disease, cardiovascular effects, sustained functional impairment and death.
-
Therapies for blood pressure control, glycaemic control (for patients with diabetes), renin–angiotensin inhibition and statins might be important in improving long-term cardiovascular and kidney outcomes after AKI.
-
Novel strategies for follow-up care, including specialized nephrology care and risk-stratified follow-up, are being evaluated in high-income countries for patients discharged following AKI.
-
Care for AKI in low-income and middle-income countries poses additional barriers due to limited resources for diagnosis and management; the International Society of Nephrology has identified approaches to addressing these challenge
Similar content being viewed by others
References
Lameire, N. H. et al. Acute kidney injury: an increasing global concern. Lancet 382, 170–179 (2013).
Mehta, R. L. et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385, 2616–2643 (2015).
Hoste, E. A. J. et al. Global epidemiology and outcomes of acute kidney injury. Nat. Rev. Nephrol. 14, 607–625 (2018).
Levey, A. S. & James, M. T. Acute kidney injury. Ann. Intern. Med. 167, Itc66–Itc80 (2017).
Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V. & Bates, D. W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 16, 3365–3370 (2005).
Molitoris, B. A. et al. Improving outcomes of acute kidney injury: report of an initiative. Nat. Clin. Pract. Nephrol. 3, 439–442 (2007).
See, E. J. et al. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int. 95, 160–172 (2019).
Olowu, W. A. et al. Outcomes of acute kidney injury in children and adults in sub-Saharan Africa: a systematic review. Lancet Glob. Health 4, e242–e250 (2016).
Mehta, R. L. et al. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet 387, 2017–2025 (2016).
Kellum, J. A., Sileanu, F. E., Bihorac, A., Hoste, E. A. & Chawla, L. S. Recovery after acute kidney injury. Am. J. Respir. Crit. Care Med. 195, 784–791 (2017).
Siew, E. D. et al. Predictors of recurrent AKI. J. Am. Soc. Nephrol. 27, 1190–1200 (2016).
Liu, K. D. et al. Risk factors for recurrent acute kidney injury in a large population-based cohort. Am. J. Kidney Dis. 73, 163–173 (2019).
Rocco, M. V. et al. Effects of intensive blood pressure treatment on acute kidney injury events in the Systolic Blood Pressure Intervention Trial (SPRINT). Am. J. Kidney Dis. 71, 352–361 (2018).
Beldhuis, I. E. et al. Renin–angiotensin system inhibition, worsening renal function, and outcome in heart failure patients with reduced and preserved ejection fraction: a meta-analysis of published study data. Circ. Heart Fail. 10, e003588 (2017).
Rao, V. S. et al. Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circ. Heart Fail. 12, e005552 (2019).
Silver, S. A. et al. 30-day readmissions after an acute kidney injury hospitalization. Am. J. Med. 130, 163–172.e164 (2017).
Sawhney, S. et al. Acute kidney injury as an independent risk factor for unplanned 90-day hospital readmissions. BMC Nephrol. 18, 9 (2017).
James, M. T. et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ. Cardiovasc. Interv. 6, 37–43 (2013).
Go, A. S. et al. Acute kidney injury and risk of heart failure and atherosclerotic events. Clin. J. Am. Soc. Nephrol. 13, 833–841 (2018).
Go, A. S. et al. The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 11, 22 (2010).
Hsu, C. et al. Impact of AKI on urinary protein excretion: analysis of two prospective cohorts. J. Am. Soc. Nephrol. 30, 1271–1281 (2019).
Ronco, C., Haapio, M., House, A. A., Anavekar, N. & Bellomo, R. Cardiorenal syndrome. J. Am. Coll. Cardiol. 52, 1527–1539 (2008).
Palazzuoli, A. et al. Patients with cardiorenal syndrome revealed increased neurohormonal activity, tubular and myocardial damage compared to heart failure patients with preserved renal function. Cardiorenal Med. 4, 257–268 (2014).
Rangaswami, J. et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 139, e840–e878 (2019).
Liu, S. Heart-kidney interactions: mechanistic insights from animal models. Am. J. Physiol. Renal Physiol. 316, F974–F985 (2019).
Hsu, C. Y. et al. Elevated BP after AKI. J. Am. Soc. Nephrol. 27, 914–923 (2016).
James, M. T. et al. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet 376, 2096–2103 (2010).
Silver, S. A. et al. Causes of death after a hospitalization with AKI. J. Am. Soc. Nephrol. 29, 1001–1010 (2018).
Rosner, M. H. & Perazella, M. A. Acute kidney injury in the patient with cancer. Kidney Res. Clin. Pract. 38, 295 (2019).
Susantitaphong, P. et al. World incidence of AKI: a meta-analysis. Clin. J. Am. Soc. Nephrol. 8, 1482–1493 (2013).
Coca, S. G., Singanamala, S. & Parikh, C. R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 81, 442–448 (2012).
Pannu, N., James, M., Hemmelgarn, B., Klarenbach, S. & Network, A. K. D. Association between AKI, recovery of renal function, and long-term outcomes after hospital discharge. Clin. J. Am. Soc. Nephrol. 8, 194–202 (2013).
Heung, M. et al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans health administration data. Am. J. Kidney Dis. 67, 742–752 (2016).
Hickson, L. J. et al. Predictors of outpatient kidney function recovery among patients who initiate hemodialysis in the hospital. Am. J. Kidney Dis. 65, 592–602 (2015).
Lee, B. J. et al. Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury. Kidney Int. 93, 968–976 (2018).
Venkatachalam, M. A. et al. Acute kidney injury: a springboard for progression in chronic kidney disease. Am. J. Physiol. Renal Physiol. 298, F1078–F1094 (2010).
KDIGO AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, 1–138 (2012).
Lewington, A. & Kanagasundaram, S. Renal association clinical practice guidelines on acute kidney injury. Nephron 118, c349 (2011).
Ftouh, S. & Thomas, M. Acute kidney injury: summary of NICE guidance. BMJ 347, f4930 (2013).
Parr, S. K. et al. Acute kidney injury is a risk factor for subsequent proteinuria. Kidney Int. 93, 460–469 (2018).
Heung, M. et al. Centers for disease control and prevention CKD surveillance team. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of Veterans Health Administration data. Am. J. Kidney Dis. 67, 742–752 (2016).
James, M. T. et al. Derivation and external validation of prediction models for advanced chronic kidney disease following acute kidney injury. JAMA 318, 1787–1797 (2017).
Schiffl, H. & Fischer, R. Clinical cause of presumed acute tubular necrosis requiring renal replacement therapy and outcome of critically ill patients: post hoc analysis of a prospective 7-year cohort study. Int. Urol. Nephrol. 44, 1779–1789 (2012).
Mehta, R. L. et al. Sepsis as a cause and consequence of acute kidney injury: program to improve care in acute renal disease. Intensive Care Med. 37, 241–248 (2011).
Reynvoet, E. et al. Epidemiology of infection in critically ill patients with acute renal failure. Crit. Care Med. 37, 2203–2209 (2009).
Lai, T.-S. et al. Risk of developing severe sepsis after acute kidney injury: a population-based cohort study. Crit. Care 17, R231 (2013).
Griffin, B. R. et al. Incident infection following acute kidney injury with recovery to baseline creatinine: a propensity score matched analysis. PLOS ONE 14, e0217935 (2019).
Villeneuve, P. M., Clark, E. G., Sikora, L., Sood, M. M. & Bagshaw, S. M. Health-related quality-of-life among survivors of acute kidney injury in the intensive care unit: a systematic review. Intensive Care Med. 42, 137–146 (2016).
Abdel-Kader, K. et al. Acute kidney injury and subsequent frailty status in survivors of critical illness: a secondary analysis. Crit. Care Med. 46, e380–e388 (2018).
Coca, S. G., King, J. T. Jr, Rosenthal, R. A., Perkal, M. F. & Parikh, C. R. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int. 78, 926–933 (2010).
Lachance, P. et al. Association between e-alert implementation for detection of acute kidney injury and outcomes: a systematic review. Nephrol. Dialysis Transplant. 32, 265–272 (2017).
Al-Jaghbeer, M., Dealmeida, D., Bilderback, A., Ambrosino, R. & Kellum, J. A. Clinical decision support for in-hospital AKI. J. Am. Soc. Nephrol. 29, 654–660 (2018).
Kolhe, N. V. et al. Impact of compliance with a care bundle on acute kidney injury outcomes: a prospective observational study. PLOS ONE 10, e0132279 (2015).
Wilson, F. P. et al. Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. Lancet 385, 1966–1974 (2015).
Selby, N. M. et al. An organizational-level program of intervention for AKI: a pragmatic stepped wedge cluster randomized trial. J. Am. Soc. Nephrol. 30, 505–515 (2019).
Garg, A. X. et al. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: a randomized clinical trial. JAMA 311, 2191–2198 (2014).
Coca, S. G. et al. Evaluation of short-term changes in serum creatinine level as a meaningful end point in randomized clinical trials. J. Am. Soc. Nephrol. 27, 2529–2542 (2016).
Meersch, M. et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 43, 1551–1561 (2017).
Hsu, C.-y. et al. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin. J. Am. Soc. Nephrol. 4, 891–898 (2009).
Stevens, P. E. & Levin, A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann. Intern. Med. 158, 825–830 (2013).
Tonelli, M. et al. Statin use and the risk of acute kidney injury in older adults. BMC Nephrol. 20, 103 (2019).
Dormuth, C. R. et al. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ 346, f880 (2013).
Argalious, M., Xu, M., Sun, Z., Smedira, N. & Koch, C. G. Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery. Anesth. Analg. 111, 324–330 (2010).
Brunelli, S. M. et al. Preoperative statin use and postoperative acute kidney injury. Am. J. Med. 125, 1195–1204. e1193 (2012).
Billings, F. T. et al. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA 315, 877–888 (2016).
Zhao, B.-C., Shen, P. & Liu, K.-X. Perioperative statins do not prevent acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials. J. Cardiothorac. Vasc. Anesth. 31, 2086–2092 (2017).
Tonelli, M. & Wanner, C. Kidney disease: improving global outcomes (KDIGO) lipid work group. KDIGO clinical practice guideline for lipid management in chronic kidney disease. Kidney Int. Suppl. 3, 1–315 (2013).
Brar, S. et al. Statin use and survival after acute kidney injury. Kidney Int. Rep. 1, 279–287 (2016).
Tomson, C. & Tomlinson, L. A. Stopping RAS inhibitors to minimize AKI: more harm than good? Clin. J. Am. Soc. Nephrol. 14, 617–619 (2019).
Whiting, P. et al. What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis. BMJ Open 7, e012674 (2017).
Gayat, E. et al. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury. Intensive Care Med. 44, 598–605 (2018).
Brar, S. et al. Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with outcomes after acute kidney injury. JAMA Intern. Med. 178, 1681–1690 (2018).
Zhang, X., Donnan, P. T., Bell, S. & Guthrie, B. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol. 18, 256 (2017).
Lipworth, L. et al. High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort study. BMC Nephrol. 17, 189 (2016).
Busse, J. W. et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ 189, E659–E666 (2017).
Kitchlu, A. et al. Acute kidney injury in patients receiving systemic treatment for cancer: a population-based cohort study. J. Natl Cancer Inst. 111, 727–736 (2018).
Hung, A. M. et al. Risk of hypoglycemia following hospital discharge in patients with diabetes and acute kidney injury. Diabetes Care 41, 503–512 (2018).
Perkovic, V. et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N. Engl. J. Med. 380, 2295–2306 (2019).
Gilbert, R. E. & Thorpe, K. E. Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: a meta-analysis of cardiovascular outcome trials. Diabetes Obes. Metab. 21, 1996–2000 (2019).
Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada. Can. J. Diabetes 42, S1–S325 (2018).
Martindale, A. M. et al. Understanding the implementation of ‘sick day guidance’ to prevent acute kidney injury across a primary care setting in England: a qualitative evaluation. BMJ Open 7, e017241 (2017).
Doerfler, R. M. et al. Usability testing of a sick-day protocol in CKD. Clin. J. Am. Soc. Nephrol. 14, 583–585 (2019).
Feltner, C. et al. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann. Intern. Med. 160, 774–784 (2014).
Ayanian, J. Z., Landrum, M. B., Guadagnoli, E. & Gaccione, P. Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction. N. Engl. J. Med. 347, 1678–1686 (2002).
Harel, Z. et al. Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int. 83, 901–908 (2013).
Siew, E. D. et al. Outpatient nephrology referral rates after acute kidney injury. J. Am. Soc. Nephrol. 23, 305–312 (2012).
United States Renal Data System. 2018 annual data report: epidemiology of kidney disease in the United States (USRDS, 2018).
Karsanji, D. J. et al. Disparity between nephrologists’ opinions and contemporary practices for community follow-up after AKI hospitalization. Clin. J. Am. Soc. Nephrol. 12, 1753–1761 (2017).
Silver, S. A. et al. What insights do patients and caregivers have on acute kidney injury and posthospitalisation care? A single-centre qualitative study from Toronto, Canada. BMJ Open 8, e021418 (2018).
Phipps, D. L., Morris, R. L., Blakeman, T. & Ashcroft, D. M. What is involved in medicines management across care boundaries? A qualitative study of healthcare practitioners’ experiences in the case of acute kidney injury. BMJ Open 7, e011765 (2017).
Lunyera, J., Kilonzo, K., Lewington, A., Yeates, K. & Finkelstein, F. O. Acute kidney injury in low-resource settings: barriers to diagnosis, awareness, and treatment and strategies to overcome these barriers. Am. J. Kidney Dis. 67, 834–840 (2016).
Silver, S. A. et al. Ambulatory care after acute kidney injury: an opportunity to improve patient outcomes. Can. J. Kidney Health Dis. 2, 36 (2015).
Silver, S. A. et al. Improving care after acute kidney injury: a prospective time series study. Nephron 131, 43–50 (2015).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02483039 (2018).
Stoumpos, S., Mark, P. B., McQuarrie, E. P., Traynor, J. P. & Geddes, C. C. Continued monitoring of acute kidney injury survivors might not be necessary in those regaining an estimated glomerular filtration rate >60 mL/min at 1 year. Nephrol. Dial. Transplant. 32, 81–88 (2017).
Sawhney, S. et al. Predicting kidney failure risk after acute kidney injury among people receiving nephrology clinic care. Nephrol. Dial. Transplant. https://doi.org/10.1093/ndt/gfy294 (2018).
Steyerberg, E. in Clinical Prediction Models 299–311 (Springer, 2009).
Vickers, A. J., Van Calster, B. & Steyerberg, E. W. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ 352, i6 (2016).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02915575 (2018).
Coca, S. G. et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J. Am. Soc. Nephrol. 25, 1063–1071 (2014).
Koyner, J. L. et al. Tissue inhibitor metalloproteinase-2 (TIMP-2) IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J. Am. Soc. Nephrol. 26, 1747–1754 (2015).
National Institute of Diabetes and Digestive and Kidney Diseases. Improving care for patients after hospitalization with AKI (NIDDK, 2019).
Forni, L. et al. Renal recovery after acute kidney injury. Intensive Care Med. 43, 855–866 (2017).
Schmitt, R. et al. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am. J. Kidney Dis. 52, 262–271 (2008).
Collister, D. et al. Health care costs associated with AKI. Clin. J. Am. Soc. Nephrol. 12, 1733–1743 (2017).
Silver, S. A. & Chertow, G. M. The economic consequences of acute kidney injury. Nephron 137, 297–301 (2017).
Moosa, M. & Kidd, M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int. 70, 1107–1114 (2006).
Coca, S. G., Peixoto, A. J., Garg, A. X., Krumholz, H. M. & Parikh, C. R. The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. Am. J. Kidney Dis. 50, 712–720 (2007).
James, M. T. et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int. 78, 803–809 (2010).
Odutayo, A. et al. AKI and long-term risk for cardiovascular events and mortality. J. Am. Soc. Nephrol. 28, 377–387 (2017).
Sawhney, S., Mitchell, M., Marks, A., Fluck, N. & Black, C. Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review. BMJ Open 5, e006497 (2015).
Acknowledgements
M.T.J. was supported by Canadian Institutes of Health Research (CIHR) New Investigator Award. M.T.J. and M.T. were supported by a CIHR Foundation award.
Author information
Authors and Affiliations
Contributions
M.T.J. and M.B. researched data for the article and wrote the manuscript. N.P. and M.T. made substantial contributions to discussions of the content and reviewed or edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
M.T.J. has received funding from an investigator-initiated research grant from Amgen Canada. The other authors declare no competing interests.
Additional information
Peer review information
Nature Reviews Nephrology thanks S. Faubel and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Glossary
- Propensity-matched cohort study
-
A statistical method of analysis of observational data that uses a statistical matching technique to estimate the effect of a treatment by matching treated and untreated study participants with a similar propensity for treatment, based on the observed covariates that predict receiving the treatment.
- Stepped-wedge trial
-
A type of cluster randomized trial that involves the collection of observations during a baseline period in which no clusters are exposed to the intervention; following this period, clusters are randomized to receive the intervention in steps, until all clusters have received the intervention.
- Medication reconciliation
-
The process of comparing the medication orders of a patient with the list of medications that the patient has been taking to avoid medication errors such as omissions, duplications, dosing errors or drug interactions.
- ‘sick day medication guidance’
-
Advice provided to patients about symptoms and certain drugs that should be temporarily discontinued during acute intercurrent illnesses, particularly where the fluid balance is disturbed.
- Concordance statistic
-
A measure of model performance that assesses discrimination (the ability of the model to separate individuals who develop events from those who do not).
Rights and permissions
About this article
Cite this article
James, M.T., Bhatt, M., Pannu, N. et al. Long-term outcomes of acute kidney injury and strategies for improved care. Nat Rev Nephrol 16, 193–205 (2020). https://doi.org/10.1038/s41581-019-0247-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-019-0247-z
- Springer Nature Limited
This article is cited by
-
Inhibition of Drp1- Fis1 interaction alleviates aberrant mitochondrial fragmentation and acute kidney injury
Cellular & Molecular Biology Letters (2024)
-
Ultrasonographic assessment of renal microcirculation is a new vision for the treatment of intensive care unit associated acute kidney injury
European Journal of Medical Research (2024)
-
Influence of fluid accumulation on major adverse kidney events in critically ill patients – an observational cohort study
Annals of Intensive Care (2024)
-
Predictive enrichment for the need of renal replacement in sepsis-associated acute kidney injury: combination of furosemide stress test and urinary biomarkers TIMP-2 and IGFBP-7
Annals of Intensive Care (2024)
-
Autophagy-deficient macrophages exacerbate cisplatin-induced mitochondrial dysfunction and kidney injury via miR-195a-5p-SIRT3 axis
Nature Communications (2024)